IPT is an alternative cancer treatment that has almost none of the side effects such as nausea, radical hair loss, liver damage, and DNA distortion that we see routinely with standard chemotherapy. The key to IPT as a cancer cure is the body’s own hormone.
To learn more about IPT, please take a moment to view a presentation on this treatment prepared by Dr. Frank George. This presentation includes the advantages of IP therapy, case studies, and an outline of the 4-fold approach to IPT taken by the doctors at EuroMed Foundation. You may also visit our FAQ page for answers to commonly asked questions about IPT.
IP therapy manages the delivery of glucose across cell membranes into the cells. Cancer cells have 10-20 times more hormone receptors on their surface than normal cells. When hormone is released into the bloodstream by the pancreas in response to a meal, the hormone attaches to these receptors on the surface of the cell and, like a key fitting into a lock, opens channels in the cell wall to allow nutrients to go into the cell. Because cancer cells have more of these receptors, they compete for food better than normal cells. In this way, cancer cells thrive and normal cells are compromised.
To find out more about how the EuroMed Foundation uses IPT as a cancer cure, request your free personal orientation online. One of our doctors will be happy to answer your basic questions in person or over the phone.
SUGAR – THE SWEET SPOT FOR CANCER
You may have heard the expression, “sugar feeds cancer.” Indeed it does. Yet at the same time, sugar is the Achilles heel of cancer.
PET scans for example find cancer by looking at the sugar uptake. The radioactive agent is mixed with sugar water and, because cancer cells take up much more sugar than normal cells, the radioactive agent congregates in the cancer cells. The resulting picture will indicate enhanced uptake and a mass where the cancer is.
Hormone manages the delivery of glucose across cell membranes into the cells. Cancer cells have 10-20 times more hormone receptors on their surface than normal cells. When hormone is released into the bloodstream by the pancreas in response to a meal, the hormone attaches to these receptors on the surface of the cell and, like a key fitting into a lock, opens channels in the cell wall to allow nutrients to go into the cell. Because cancer cells have more of these receptors, they compete for food better than normal cells. In this way, cancer cells thrive and normal cells are compromised.We use that extreme need for sugar to our advantage with IPT when treating cancer. But instead of using a radioactive agent along with the sugar, we use chemotherapy. And we open the cellular membranes for significantly better absorption.
In IPT, we administer hormone to trigger a drop in the patient’s blood sugar level. Healthy cells shift over to fat metabolism, but cancer cells rely almost entirely on sugar metabolism, so they go into an emergency mode and open all of their membranes in an effort to get the sugar they so desperately need. We have the cancer cells now in a very vulnerable position.
At this point, we administer a small amount of chemotherapy followed quickly by glucose (sugar). The cancer cells, in their desperate effort to get the glucose, take in almost the entire dose of chemotherapy drugs as well. The drugs poison and eventually kill the cancer cells.
How small a dose of drugs do we use? About one-tenth the amount of standard chemotherapy. That is why IPT is also known as low dose chemotherapy.
This method allows us to target the cytotoxic drugs directly to the cancer cell. There is little chemo left over to cause a toxic reaction within healthy cells. Patients who treat cancer with IPT have far fewer side effects.
In standard chemotherapy, hormone is not used to open the cells. Patients must be given a large dose of drugs so that enough will be absorbed by the cells to do the job. The majority of the drugs are not taken up by the cancer cells; the massive dosage wreaks havoc to healthy cells and blood components. Standard chemotherapy does not target cancer cells. The immune system takes a beating and patients experience many unpleasant side effects.
ABILITY TO POTENTIATE
The word “potentiate” means that one substance, used in IP therapy enhances the effectiveness of another substance – chemotherapy – and thus far less drugs are needed.
Simply put, IPT consists of a pulse of hypoglycemia (low blood sugar) that improves the effectiveness of therapeutic drugs and supports health:
IPT makes cell membranes more permeable, increasing the uptake of drugs into cells. IPT can help transport drugs across the blood-brain barrier. Hormone used in IPT, in addition to its ability to help deliver higher-levels of the chemotherapy drugs into the cancer cells, also causes these cells to go into their growth phase where they actually become more vulnerable to the chemotherapy drugs. The cells are hit harder and at a time when they are most vulnerable to the assault, thus maximizing results. The practice of IPT is now worldwide. It is not yet taught in America’s conventional medical schools, however. Medical school curriculum in the U.S. focuses mostly on hormone role in diabetes. Pharmaceutical companies do not look favorably upon IPT because it uses so little of their product.
Diabetic patients need special attention and care. They can be treated by very experienced IPT physicians and with IPT using lower doses of hormone.